Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.
3.

Cefditoren, a new aminothiazolyl cephalosporin.

Balbisi EA.

Pharmacotherapy. 2002 Oct;22(10):1278-93. Review.

PMID:
12389878
5.

[Cefditoren and community-acquired lower respiratory tract infections (corrected)].

Barberán J, Mensa J.

Rev Esp Quimioter. 2009 Sep;22(3):144-50. Review. Spanish. Erratum in: Rev Esp Quimioter. 2011 Mar;24(1):56.

6.

Cefditoren pivoxil versus cefpodoxime proxetil for community-acquired pneumonia: results of a multicenter, prospective, randomized, double-blind study.

van Zyl L, le Roux JG, LaFata JA, Volk RS, Palo WA, Flamm R, Hom RC.

Clin Ther. 2002 Nov;24(11):1840-53.

PMID:
12501878
7.

Cefditoren in upper and lower community-acquired respiratory tract infections.

Soriano F, Giménez MJ, Aguilar L.

Drug Des Devel Ther. 2011 Feb 9;5:85-94. doi: 10.2147/DDDT.S9499. Review.

8.

Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.

Appelbaum PC, Gillespie SH, Burley CJ, Tillotson GS.

Int J Antimicrob Agents. 2004 Jun;23(6):533-46. Review.

PMID:
15194123
9.

In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.

Yang Q, Xu Y, Chen M, Wang H, Sun H, Hu Y, Zhang R, Duan Q, Zhuo C, Cao B, Liu Y, Yu Y, Sun Z, Chu Y.

Diagn Microbiol Infect Dis. 2012 Jun;73(2):187-91. doi: 10.1016/j.diagmicrobio.2012.03.005. Epub 2012 Apr 21.

PMID:
22521692
10.

Spotlight on cefditoren pivoxil in bacterial infections.

Wellington K, Curran MP.

Treat Respir Med. 2005;4(2):149-52. Review.

PMID:
15813670
11.

Microbiological diagnosis and antibiotic therapy in patients with community-acquired pneumonia and acute COPD exacerbation in daily clinical practice: comparison to current guidelines.

Reissig A, Mempel C, Schumacher U, Copetti R, Gross F, Aliberti S.

Lung. 2013 Jun;191(3):239-46. doi: 10.1007/s00408-013-9460-x. Epub 2013 Apr 6.

PMID:
23564195
12.

A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic.

File TM Jr, Monte SV, Schentag JJ, Paladino JA, Klugman KP, Lavin B, Yu VL, Singer ME, Adelman MH.

Int J Antimicrob Agents. 2009 Jan;33(1):58-64. doi: 10.1016/j.ijantimicag.2008.07.019. Epub 2008 Oct 1.

PMID:
18835762
14.

Cefditoren pivoxil.

Darkes MJ, Plosker GL.

Drugs. 2002;62(2):319-36; discussion 337-8. Review.

PMID:
11817976
15.

Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.

Perry CM, Scott LJ.

Drugs. 2004;64(13):1433-64. Review.

PMID:
15212560
17.

Cefditoren pivoxil: a review of its use in the treatment of bacterial infections.

Wellington K, Curran MP.

Drugs. 2004;64(22):2597-618. Review.

PMID:
15516158
18.

[Efficacy and safety of cefditoren pivoxil in treatment of respiratory infections, a clinical study].

Li JT, Gao L, Xue F, Hao FL, Wang Q, Cai BQ, Gan CL, Liu YN, Yu BX, He LX, Hu BJ, Chen XH, Zheng JC, Yu YS, Lu FF, Liang DR, Cai YN, Kang J, Kong LF, Xiao ZL, Zheng JP, Liu J, Yang WX, Zhou J.

Zhonghua Yi Xue Za Zhi. 2003 Mar 10;83(5):391-4. Chinese.

PMID:
12820915
19.

Safety profile of cefditoren. A pooled analysis of data from clinical trials in community-acquired respiratory tract infections.

Granizo JJ, Aguilar L, Gimenez MJ, Coronel P, Gimeno M, Prieto J.

Rev Esp Quimioter. 2009 Jun;22(2):57-61.

Supplemental Content

Support Center